ストックスクリーナーアプリを入手
1.19
0.83%
-0.01
アフターアワーズ：
1.18
-0.01
-0.84%
iBio Inc (IBIO) 最新ニュース
IBIO INC (IBIO) Stock Chart - ChartMill
iBio Inc. Share PriceIBIO, RNS News, Articles, Quotes, & Charts (NASDAQ:IBIO) - proactiveinvestors.com
HC Wainwright Comments on iBio's Q1 Earnings (NASDAQ:IBIO) - MarketBeat
IBIO Q2 2026 Earnings: Wider-Than-Expected Loss, Yet Shares Edge HigherFinancial Data - dars.gov.et
Ibio Stock Price Forecast. Should You Buy IBIO? - StockInvest.us
iBio, Inc. Common Stock (NASDAQ: IBIO) Share Price, IBIO Stock News, IBIO Share Price & Updates - kalkine.com.au
HC Wainwright Upgrades iBio (NASDAQ:IBIO) to Strong-Buy - MarketBeat
H.C. Wainwright Initiates IBio Inc(IBIO.US) With Buy Rating, Announces Target Price $7 - Moomoo
iBio stock initiated at buy by H.C. Wainwright with $7 target - Investing.com South Africa
HC Wainwright Initiates iBio With Buy Rating, $7 Price Target - Yahoo Finance
This Paymentus Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
IBIO Initiates Coverage On by HC Wainwright & Co. -- Price Targe - GuruFocus
IBio Price Target Announced at $7.00/Share by HC Wainwright & Co. - Moomoo
HC Wainwright & Co. initiates coverage of iBio with Buy rating, $7 price target - TradingView
Ibio, Inc. : H.c. Wainwright Initiates Covera - Moomoo
iBio Inc (0JV0.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
Form 8K Ibio Inc For: 14 September By Investing.com - Investing.com Australia
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
iBio updates corporate presentation, details pipeline milestones and $88M cash runway - TradingView
New iBio (NASDAQ: IBIO) investor presentation goes public - Stock Titan
iBio (NASDAQ:IBIO) Stock Rating Lowered by Wall Street Zen - MarketBeat
iBio, Inc. (IBIO) Stock Price & News - Syfe
IBIO Q2 2026 Earnings: EPS Beat Provides Minor Lift as Revenue Remains AbsentOperating Income Trends - dars.gov.et
iBio at Wells Fargo healthcare conference: obesity pipeline takes shape By Investing.com - Investing.com South Africa
iBio at Wells Fargo healthcare conference: obesity pipeline takes shape - Investing.com
iBio (NASDAQ: IBIO) Shareholders Set to Vote on 500 Million Share Increase on October 14, 2026 - Kalkine Media
iBio (NASDAQ:IBIO) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
iBio, Inc. SEC Filing (Sep 4, 2026) - stocktitan.net
Hundreds of millions of new shares on ballot at iBio (IBIO) - Stock Titan
PharmaCyte Biotech Inc (PMCB) Peer Comparison – Compare with Others - Value Research
iBio, Inc. (NASDAQ:IBIO) Receives Average Rating of "Buy" from Brokerages - marketbeat.com
iBio Q2 EPS Forecast Decreased by Brookline Capital Markets - MarketBeat
iBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference - The Manila Times
Insiders Give Up US$33k As iBio Stock Drops To US$1.27 - simplywall.st
iBio Inc. (IBIO) Slides 6.6% to $1.27 as Biotech Stock Approaches Key SupportWyckoff Distribution - dars.gov.et
B. Riley Securities Initiates IBio Inc(IBIO.US) With Buy Rating, Announces Target Price $6 - moomoo.com
iBio Advances IBIO-600 Through First Phase 1 Dose Escalation As Cash And Investments Reach $88 Million - Pulse 2.0
iBio Inc. Q2 2026 Earnings: Narrower Loss Per Share Slightly Beats Estimates, Stock Slips 2.86%ROIC Trend Report - dars.gov.et
iBio, Inc. Revenue Breakdown – NASDAQ:IBIO - TradingView
iBio FY2026 Net Loss Widens to $33M on Higher R&D Spending - Minichart
iBio FY 2026: Revenue $100K, Net income ($33.04M), EPS ($0.32) — 10-K Summary - TradingView
iBio reports $33 million loss for fiscal 2026, advances pipeline By Investing.com - Investing.com Canada
IBio Reports $33.0 Million Fiscal 2026 Net Loss as Phase 1 Advances - Moomoo
iBio Reports $33.0 Million Fiscal 2026 Net Loss as Phase 1 Advances - Quiver Quantitative
IBIO: Advanced clinical pipeline and secured funding, extending cash runway into fiscal 2028 - TradingView
iBio (NASDAQ:IBIO) Releases Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
iBio reports FY2026 net loss of $33.0M, revenue $0.1M and $88.0M cash and investments - TradingView
iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update - The Manila Times
iBio Reports Fiscal 2026 Financial Results and Corporate Update Highlighting Clinical and Pipeline Progress - Quiver Quantitative
IBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update - marketscreener.com
iBio FY26 Results: Net loss widens 80% to $33.0M, R&D up 136% - scanx.trade
iBio (IBIO) Expected to Release Quarterly Earnings on Friday - MarketBeat
iBio (NYSE: IBIO) seeks 500M shares, revises equity plan for warrants - Stock Titan
iBio (IBIO) Chart: Closes 1.72% Lower at $1.43 for the Current Session; Current Setup: the Near-Term Reference Band Stretches From $1.36 to $1.50 in the Available RecordMax Pain Level - vinanet.vn
3.06%
2.55%
大文字化:
|
ボリューム (24 時間):